CIMADOMO, DANILO
 Distribuzione geografica
Continente #
NA - Nord America 2.966
AS - Asia 816
EU - Europa 428
SA - Sud America 109
AF - Africa 20
OC - Oceania 1
Totale 4.340
Nazione #
US - Stati Uniti d'America 2.922
SG - Singapore 437
CN - Cina 181
GB - Regno Unito 121
BR - Brasile 85
IT - Italia 84
HK - Hong Kong 62
IE - Irlanda 59
RU - Federazione Russa 51
VN - Vietnam 46
IN - India 32
DE - Germania 28
CA - Canada 21
MX - Messico 20
PL - Polonia 18
JP - Giappone 16
FI - Finlandia 15
NL - Olanda 13
ZA - Sudafrica 12
AR - Argentina 11
SE - Svezia 11
ID - Indonesia 8
LT - Lituania 6
AT - Austria 5
CH - Svizzera 5
IR - Iran 5
EC - Ecuador 4
ES - Italia 4
IQ - Iraq 4
NG - Nigeria 4
AE - Emirati Arabi Uniti 3
PK - Pakistan 3
TR - Turchia 3
BD - Bangladesh 2
CL - Cile 2
FR - Francia 2
IL - Israele 2
PE - Perù 2
SA - Arabia Saudita 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
NI - Nicaragua 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
Totale 4.340
Città #
Dallas 2.369
Singapore 121
Ashburn 99
Hong Kong 62
Dublin 59
Los Angeles 49
New York 44
Beijing 35
Chandler 25
Boardman 18
Munich 17
Poplar 17
Redondo Beach 17
Warsaw 16
Denver 14
Montreal 14
Tianjin 14
Council Bluffs 13
Ho Chi Minh City 13
Buffalo 12
Chennai 12
Mexico City 12
Orem 12
Houston 11
Stockholm 11
São Paulo 11
Tokyo 11
Hanoi 10
Pavia 10
Helsinki 9
Johannesburg 9
Milan 9
Brooklyn 8
Moscow 8
Nanjing 8
Rome 8
Santa Clara 8
Bengaluru 7
Florence 7
Manchester 7
Phoenix 7
Shanghai 7
Shenyang 7
Boston 6
London 6
Padova 6
Xi'an 6
Amsterdam 5
Atlanta 5
Jacksonville 5
Wilmington 5
Belo Horizonte 4
Castano Primo 4
Chicago 4
Falls Church 4
Karaj 4
Lagos 4
Moriguchi 4
Querétaro 4
Toronto 4
Ankara 3
Brasília 3
Brescia 3
Lawrence 3
Medford 3
Monza 3
Nuremberg 3
Princeton 3
Rio de Janeiro 3
San Jose 3
Seattle 3
Thái Bình 3
Waltham Forest 3
Zurich 3
Annapolis 2
Bari 2
Bloemfontein 2
Campo Grande 2
Charlotte 2
Chengdu 2
Elk Grove Village 2
Florianópolis 2
Garbagnate Milanese 2
Goiânia 2
Grand Rapids 2
Guadalajara 2
Guayaquil 2
Hangzhou 2
Hyderabad 2
Hải Dương 2
Jakarta 2
Louisville 2
Miami 2
Mosul 2
Passo Fundo 2
Porto Alegre 2
Pudsey 2
Pune 2
Roncadelle 2
San Francisco 2
Totale 3.411
Nome #
In vitro fertilization and andrology laboratory in 2030: expert visions 154
Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists 148
Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers 144
Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population 128
Corrigendum. Definition of a clinical strategy to enhance the efficacy, efficiency and safety of egg donation cycles with imported vitrified oocytes 122
The effect of extended cryo-storage following vitrification on embryo competence: a systematic review and meta-analysis 97
A multi-cycle approach via DuoStim is beneficial to treat couples indicated to PGT-M plus PGT-A. A propensity score matching-based case series 95
In vitro fertilization and andrology laboratories in 2030 94
Improved clinical utility of preimplantation genetic testing through the integration of ploidy and common pathogenic microdeletions analyses 92
NOBOX, a marker of oocyte developmental competence 88
The NOBOX protein becomes undetectable in developmentally competent antral and ovulated oocytes. 86
Female fertility preservation for family planning: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) 81
Endocrine-Disrupting Chemicals, Gut Microbiota, and Human (In)Fertility - It Is Time to Consider the Triad 80
Cumulus cells secrete micro-vesicles carrying miRNAs: their role in the acquisition of mouse and human oocyte’s developmental competence 75
Extracellular vesicles secreted by cumulus cells contain microRNAs that are potential regulatory factors of mouse oocyte developmental competence 72
3D nano-Computed Tomography imaging and reconstruction of the mouse ovary before and after gonadotropins treatment 70
Maternal effect factors that contribute to oocytes developmental competence: an update 70
Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation: implications for fertility 65
A brief history of oocyte cryopreservation: Arguments and facts 61
Cytoplasmic strings in human blastocysts: hypotheses of their role and implications for embryo selection 60
Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles 59
Human embryos with segmental aneuploidies display delayed early development: a multicenter morphokinetic analysis 56
A multicycle approach through DuoStim with a progestin-primed ovarian stimulation (PPOS) protocol: a valuable option in poor prognosis patients undergoing PGT-A 55
Spent Blastocyst Media and Blastocoel Fluid are not reliable DNA sources for preimplantation genetic diagnosis of aneuploidies and monogenic disorders 51
Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials 48
ICSI and PGT-A in PCOS phenotype-D patients: a matched case–control study versus idiopathic infertile women 48
State of the art and emerging drug therapies for female infertility 48
Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle 47
The Impact of Unbalanced Maternal Nutritional Intakes on Oocyte Mitochondrial Activity: Implications for Reproductive Function 47
Multi- and Transgenerational Effects of Environmental Toxicants on Mammalian Reproduction 46
Trophectoderm biopsy does not impact embryo viability after vitrification: results from a multicentre prospective study 45
An expert opinion on rescuing atypically pronucleated human zygotes by molecular genetic fertilization checks in IVF 45
Impact of PGT Introduction on IVF Laboratory Workload: Lessons Learned from a Single-Center Experience of 5258 Biopsies over a 10-Year Period 44
When embryology meets genetics: the definition of developmentally incompetent preimplantation embryos (DIPE)-the consensus of two Italian scientific societies 43
Human blastocyst spontaneous collapse is associated with worse morphological quality and higher degeneration and aneuploidy rates: a comprehensive analysis standardized through artificial intelligence 43
The daunting goal to rescue oocytes collected immature in conventional ovarian stimulation cycles 41
Chromosomal Abnormalities and Their Reproductive Impact 41
A systematic review and meta-analysis of double trophectoderm biopsy and/or cryopreservation in PGT: balancing the need for a diagnosis against the risk of harm 41
Comprehensive examination of the ICSI-related procedural timings and their effect on mean blastulation rates per cycle 40
Maternal body mass index associates with blastocyst euploidy and live birth rates: the tip of an iceberg? 40
Oocyte vitrification for fertility preservation is an evolving practice requiring a new mindset: societal, technical, clinical, and basic science-driven evolutions 39
Early embryo ontogeny and parental genetic legacy: from developmental mechanisms to diagnosis and treatment 39
Quantitative Standardized Expansion Assay: An Artificial Intelligence-Powered Morphometric Description of Blastocyst Expansion and Zona Thinning Dynamics 38
A standardized training allows achieving similar clinical pregnancy rates per top-quality euploid blastocyst transfer across operators 37
Association between oocyte donors' or recipients' body mass index and clinical outcomes after first single blastocyst transfers-the uterus is the most affected 36
Management of Women With an Unexpected Low Ovarian Response to Gonadotropin 36
Is it in our patients' blood? On a quest for predictors of blastocysts' aneuploidy rate 35
Biochemical pregnancy loss is unrelated to embryo stage of development and euploidy at transfer: evidences from 2452 warming cycles 34
Correlation between standard blastocyst morphology, euploidy and implantation: An observational study in two centers involving 956 screened blastocysts 34
Pre-implantation genetic testing in ART: who will benefit and what is the evidence? 33
No evidence of different miRNomic profiles in the follicular fluids retrieved after stimulation conducted in follicular and luteal phase of the same ovarian cycle 32
Value of PGT-A when only one or two blastocysts are obtained: propensity-score matching and cost-effectiveness study 31
Polar Body, Cleavage Stage and Trophectoderm Biopsy 31
Artificial intelligence-based donor oocyte quality assessment moderately improves the prediction of blastocyst development: a first step towards higher personalization in the management of egg donation treatments 31
Embryo Biopsy: Polar Body, Cleavage Stage and Trophectoderm 30
Surfing follicular waves in ovarian stimulation: is there a role for LH in DuoStim protocols? A narrative review and SWOT analysis 30
Delays in the final stages of fertilization are strongly associated with trichotomous cytokinesis and cleavage arrest 30
Improved concordance rates for aneuploidy detection in spent culture media compared to trophectoderm biopsies: a step forward towards non-invasive preimplantation genetic testing (niPGT-A) 30
Genome-wide maps of recombination and chromosome segregation in human oocytes and embryos show selection for maternal recombination rates 30
Towards Automation in IVF: Pre-Clinical Validation of a Deep Learning-Based Embryo Grading System during PGT-A Cycles 26
The relevance of female overweight in infertility treatment: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) 25
Clinical outcomes of preimplantation genetic screening cycle are not related to male characteristics: observational longitudinal cohort study involving 734 consecutive cycles 25
Efficacy of heparin on in-vitro fertilization outcomes: a systematic review and SWOT analysis 23
Implementation of a new single-step culture media: a randomized control trial (RCT) on sibling oocytes 23
A WHO 2021-based comprehensive scheme outlining sperm parameters' associations with IVF outcomes in PGT-A cycles 22
Blastocoel cavity contains miRNAs: novel potential biomarker of blastocyst quality 21
Parallel analysis of copy number aneuploidies and ploidy level by NGS and SNP array on single biopsy provides accurate results and improves PGT-A applications range 21
Blastocysts from abnormally-fertilized zygotes can be euploid/diploid and are reproductively competent: live-births from preimplantation genetic diagnosis of aneuploidy/polyploidy in embryos with abnormal pronuclear morphology 20
A novel machine-learning framework based on early embryo morphokinetics identifies a feature signature associated with blastocyst development 20
Predictive value of blastocyst morphology beyond aneuploidy testing: evidences from a randomized non-selection study 19
comprehensive description of the clinical contribution of poor-quality blastocysts to live birth: analysis of 2757 oocyte retrievals with preimplantation genetic testing for aneuploidies 19
Origin of false positives and false negatives in non-invasive preimplantation genetic testing for aneuploidies 19
Aneuploidy and implantation potential of euploid blastocysts cannot be predicted by non-invasive morphokinetic analysis during in vitro culture 18
Metaphase II oocytes obtained after luteal phase stimulation have the same intrinsic quality as eggs from the follicular phase stimulation.Results from a multicentre prospective study 17
Abnormally fertilized oocytes can result in healthy live births: improved genetic technologies for preimplantation genetic testing can be used to rescue viable embryos in in vitro fertilization cycles 17
Embryos not showing pronuclei by single static observation arise from atypical pronuclear dynamics or rare unfertilized oocytes with abortive cleavage behaviour 17
Secreted miRNAs can be profiled with high accuracy and reproducibility from blastocyst spent culture media: a new potential biomarker for non-invasive embryo selection 16
Avoid mixing apples and oranges: blastocysts diagnosed with uniform whole chromosome aneuploidies are reproductively incompetent and their transfer is harmful 16
Role of TSH (Thyroid Stimulating Hormone) in the maintenance and functioning of the human corpus luteum 15
Comprehensive characterization of the human blastocyst's miRNome from the Inner Cell Mass, the Trophectoderm and their related IVF spent culture media 14
Quantitative polymerase chain reaction (qPCR)-based patterns consistent with mosaicism/partial aneuploidies(PA) indicate blastocysts with slightly lower reproductive competence: preliminary results from a non-selection study 14
Blastocyst morphology does not significantly increase the selection between euploid blastocysts in frozen embryo transfer cycles: evidences from a prospective non-selection study 13
Associations of blastocyst features, trophectoderm biopsy and other laboratory practice with post-warming behavior and implantation 13
Biochemical pregnancy loss after frozen embryo transfer seems independent of embryo developmental stage and chromosomal status 13
Gene expression pattern predictive of human ovarian follicle development and maturation 12
Perceived workplace stressors and professional experiences of clinical embryologists working in Italy and Spain: a pilot qualitative study 12
Correlation between oocyte cumulus cells gene expression, embryo morphokinetic, blastocyst formation and euploidy 11
Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial 11
Assessment and management of the risk of SARS-CoV-2 infection in an IVF laboratory 11
IVF add-ons: effectiveness, efficiency, safety, and additional costs - A position statement by the SIFES-MR 10
Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment 10
Freeze-all in poor prognosis patients: clinical outcomes of single vitrified euploid blastocyst transfers 10
An integrated investigation of oocyte developmental competence: expression of key genes in human cumulus cells, morphokinetics of early divisions, blastulation, and euploidy 9
Do we still need embryologists? 9
No evidences that implantation of vitrified euploid blastocysts is influenced by ovarian stimulation conducted in luteal vs follicular phase:interim analysis of a prospective multicentre study 8
Immunological interventions in recurrent implantation failure: a systematic review and SWOT analysis 8
DuoStim Shows Comparable Efficacy but Better Efficiency than Two Conventional Stimulations in Poor/Suboptimal Responders Undergoing Vitrified Oocyte Accumulation for PGT-A 8
Luteal after follicular-phase-stimulation in the same ovarian cycle is a promising strategy to increase the chance of delivery in poor responder women fulfilling Bologna Criteria 8
Double stimulation in a single menstrual cycle increases the number of oocytes collected in poor prognosis patients undergoing IVF treatment. Prospective study with historical control. 8
INCREASED CONCORDANCE RATES BETWEEN EMBRYO CELL-FREE DNA AND TROPHECTODERM BIOPSIES ARE RELATED TO FEMALE AGE INDEPENDENTLY OF CULTURE CONDITIONS 8
Totale 4.065
Categoria #
all - tutte 14.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 1 0 2 0 1 0 0
2021/202221 0 0 0 0 3 2 4 0 3 1 1 7
2022/2023123 6 6 0 3 10 7 0 19 63 5 3 1
2023/202474 4 16 7 5 10 8 8 1 0 6 2 7
2024/2025278 6 17 11 7 12 24 41 17 69 11 24 39
2025/20264.086 43 31 2.631 623 494 264 0 0 0 0 0 0
Totale 4.620